Phase II trial of sunitinib malate and lomustine in patients with temozolomide refractory recurrent low-grade and anaplastic gliomas.

被引：0
|
作者：
Duerinck, Johnny [1 ]
Du Four, Stephanie [1 ]
Van Binst, An [1 ]
Everaert, Hendrik [1 ]
Michotte, Alex [1 ]
D'haens, Jean [1 ]
Neyns, Bart [1 ]
机构：
[1] UZ Brussel, Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2050
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma
    Duerinck, Johnny
    Du Four, Stephanie
    Sander, Wilhelm
    Van Binst, Anne-Marie
    Everaert, Hendrik
    Michotte, Alex
    Hau, Peter
    Neyns, Bart
    [J]. ANTICANCER RESEARCH, 2015, 35 (10) : 5551 - 5557
  • [2] SUNITINIB MALATE IN COMBINATION WITH LOMUSTINE FOR PATIENTS WITH TEMOZOLOMIDE REFRACTORY RECURRENT WHO-GRADE II/III GLIOMAS
    Duerinck, J.
    Du Four, S.
    Van Binst, A.
    Everaert, H.
    Michotte, A.
    D'haens, J.
    Neyns, B.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 43 - 44
  • [3] Phase II trial of sunitinib malate in patients with temozolomide refractory recurrent high-grade glioma
    Neyns, B.
    Chaskis, C.
    Dujardin, M.
    Everaert, H.
    Sadones, J.
    Nupponen, N. N.
    Michotte, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] SUNITINIB MALATE AS A SINGLE AGENT OR COMBINED WITH LOMUSTINE (CCNU) IN PATIENTS WITH RECURRENT, TEMOZOLOMIDE REFRACTORY HIGH-GRADE GLIOMA
    Neyns, B.
    Lv, S.
    Chaskis, C.
    Sadones, J.
    Dujardin, M.
    Everaert, H.
    Duerinck, J.
    Nupponen, N.
    Michotte, A.
    De Greve, J.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 16 - 16
  • [5] Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial
    Chamberlain, Marc C.
    Colman, Howard
    Kim, Bryan T.
    Raizer, Jeffrey
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (03) : 507 - 516
  • [6] Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial
    Marc C. Chamberlain
    Howard Colman
    Bryan T. Kim
    Jeffrey Raizer
    [J]. Journal of Neuro-Oncology, 2017, 131 : 507 - 516
  • [7] Temozolomide and radiation in low-grade and anaplastic gliomas: Temoradiation
    Schiff, David
    [J]. CANCER INVESTIGATION, 2007, 25 (08) : 776 - 784
  • [8] A phase II trial of LY317615 in patients with recurrent high grade gliomas.
    Fine, HA
    Kim, L
    Royce, C
    Mitchell, S
    Duic, JP
    Albert, P
    Musib, L
    Thornton, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 109S - 109S
  • [9] Phase II study of extended schedule temozolomide in refractory gliomas.
    Berrocal, A.
    Perez-Segura, P.
    Gil, M.
    Balaña, C.
    Yaya-Tur, R.
    Yaya-Tur, R.
    Reynes, G.
    Garcia-Lopez, J.
    Gallego, O.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 62S - 62S
  • [10] Phase II trial of temozolomide in patients with progressive low-grade glioma
    Quinn, JA
    Reardon, DA
    Friedman, AH
    Rich, JN
    Sampson, JH
    Provenzale, JM
    McLendon, RE
    Gururangan, S
    Bigner, DD
    Herndon, JE
    Avgeropoulos, N
    Finlay, J
    Tourt-Uhlig, S
    Affronti, ML
    Evans, B
    Stafford-Fox, V
    Zaknoen, S
    Friedman, HS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) : 646 - 651
12345